Pulmonary hypertension in patients with amyloidosis.
暂无分享,去创建一个
[1] W. Edwards,et al. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. , 2000, The American journal of medicine.
[2] M. Krowka. Pulmonary hypertension: diagnostics and therapeutics. , 2000, Mayo Clinic proceedings.
[3] R. Cannon,et al. Systemic Amyloidosis Presenting with Angina Pectoris , 1999, Annals of Internal Medicine.
[4] J. Loscalzo,et al. Prothrombotic mechanisms in primary pulmonary hypertension. , 1999, The Journal of laboratory and clinical medicine.
[5] K. Kerr,et al. Right Heart Failure as the Dominant Clinical Picture in a Case of Primary Amyloidosis Affecting the Pulmonary Vasculature , 1999, Scottish medical journal.
[6] A. Dispenzieri,et al. Amyloidosis: recognition, confirmation, prognosis, and therapy. , 1999, Mayo Clinic proceedings.
[7] R. D. Murray,et al. Duration of pulmonary venous atrial reversal flow velocity and mitral inflow a wave: new measure of severity of cardiac amyloidosis. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[8] A. Fishman. Etiology and pathogenesis of primary pulmonary hypertension: a perspective. , 1998, Chest.
[9] M. Mullan,et al. Characteristics of thein VitroVasoactivity of β-Amyloid Peptides , 1998, Experimental Neurology.
[10] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[11] A. Tajik,et al. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy. , 1997, The American journal of cardiology.
[12] À. Argilés. β2‐Microglobulin amyloidosis , 1996 .
[13] W. Edwards,et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. , 1996 .
[14] S. Swensen,et al. Pulmonary Amyloidosis. The Mayo Clinic Experience from 1980 to 1993 , 1996, Annals of Internal Medicine.
[15] K. Koch,et al. Right ventricular cardiac failure and pulmonary hypertension in a long-term dialysis patient--unusual presentation of visceral beta 2-microglobulin amyloidosis. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] W. Edwards,et al. Pulmonary vascular amyloid causing pulmonary hypertension: Report of a case and review of literature , 1993 .
[17] W. J. Johnson,et al. Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association. , 1991, Mayo Clinic proceedings.
[18] A J Tajik,et al. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. , 1990, Journal of the American College of Cardiology.
[19] J. Seward,et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. , 1989, Journal of the American College of Cardiology.
[20] D. McNally,et al. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis. , 1988, Archives of internal medicine.
[21] J. Seward,et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. , 1985, Journal of the American College of Cardiology.
[22] R. Falk,et al. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. , 1985, The American journal of cardiology.